Back to Feed
Fintech
Bold Therapeutics Attending BIO-Europe Spring 2026 in Lisbon, Portugal
Prnewswire·
/PRNewswire/ -- Bold Therapeutics, a clinical-stage biopharmaceutical company that was founded to develop and commercialize novel metallotherapeutics,...
Original Source
Prnewswire — www.prnewswire.com